Literature DB >> 11968014

Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro.

Oliver Frank1, Manuel Heim, Marcel Jakob, Andrea Barbero, Dirk Schäfer, Igor Bendik, Walter Dick, Michael Heberer, Ivan Martin.   

Abstract

We developed and used real-time RT-PCR assays to investigate how the expression of typical osteoblast-related genes by human bone marrow stromal cells (BMSC) is regulated by (i) the culture time in medium inducing osteogenic differentiation and (ii) the previous expansion in medium enhancing cell osteogenic commitment. BMSC from six healthy donors were expanded in medium without (CTR) or with fibroblast growth factor-2 and dexamethasone (FGF/Dex; these factors are known to increase BMSC osteogenic commitment) and further cultivated for up to 20 days with ascorbic acid, beta-glycerophosphate and dexamethasone (these factors are typically used to induce BMSC osteogenic differentiation). Despite a high variability in the gene expression levels among different individuals, we identified the following statistically significant patterns. The mRNA levels of bone morphogenetic protein-2 (BMP-2), bone sialo protein-II (BSP), osteopontin (OP) and to a lower extent cbfa-1 increased with culture time in osteogenic medium (OM), both in CTR- and FGF/Dex-expanded BMSC, unlike levels of alkaline phosphatase, collagen type I, osteocalcin, and osteonectin. After 20 days culture in OM, BMP-2, BSP, and OP were more expressed in FGF/Dex than in CTR-expanded BMSC (mRNA levels were, respectively, 9.5-, 14.9-, and 5.8-fold higher), unlike all the other investigated genes. Analysis of single-colony-derived strains of BMSC further revealed that after 20 days culture in OM, only a subset of FGF/Dex-expanded clones expressed higher mRNA levels of BMP-2, BSP, and OP than CTR-expanded clones. In conclusion, we provide evidence that mRNA levels of BMP-2, BSP, and OP, quantified using real-time RT-PCR, can be used as markers to monitor the extent of BMSC osteogenic differentiation in vitro; using those markers, we further demonstrated that only a few subpopulations of BMSC display enhanced osteogenic differentiation following FGF/Dex expansion. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968014     DOI: 10.1002/jcb.10174

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  73 in total

1.  Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification.

Authors:  Uta Helmrich; Anna Marsano; Ludovic Melly; Thomas Wolff; Liliane Christ; Michael Heberer; Arnaud Scherberich; Ivan Martin; Andrea Banfi
Journal:  Tissue Eng Part C Methods       Date:  2011-12-19       Impact factor: 3.056

2.  [Mesenchymal stem cells for bone tissue engineering].

Authors:  R K Schneider; S Neuss; R Knüchel; A Perez-Bouza
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

3.  Shear stress induces osteogenic differentiation of human mesenchymal stem cells.

Authors:  Gregory Yourek; Susan M McCormick; Jeremy J Mao; Gwendolen C Reilly
Journal:  Regen Med       Date:  2010-09       Impact factor: 3.806

4.  In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells.

Authors:  Claude Jaquiéry; Stefan Schaeren; Jian Farhadi; Pierre Mainil-Varlet; Christoph Kunz; Hans-Florian Zeilhofer; Michael Heberer; Ivan Martin
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

5.  Mesenchymal stem cells and tissue engineering.

Authors:  Nicholas W Marion; Jeremy J Mao
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

6.  Dental follicle progenitor cell heterogeneity in the developing mouse periodontium.

Authors:  Xianghong Luan; Yoshihiro Ito; Smit Dangaria; Thomas G H Diekwisch
Journal:  Stem Cells Dev       Date:  2006-08       Impact factor: 3.272

7.  Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.

Authors:  Kristen A Wieghaus; Erwin P Gianchandani; Milton L Brown; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng       Date:  2007-10

8.  Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds.

Authors:  Joshua R Mauney; Trang Nguyen; Kelly Gillen; Carl Kirker-Head; Jeffrey M Gimble; David L Kaplan
Journal:  Biomaterials       Date:  2007-08-31       Impact factor: 12.479

9.  Effect of direct RGD incorporation in PLLA nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells.

Authors:  Markus Dietmar Schofer; Ulrich Boudriot; Sarah Bockelmann; Andreas Walz; Joachim Heinz Wendorff; Andreas Greiner; Jürgen Rudolf Josef Paletta; Susanne Fuchs-Winkelmann
Journal:  J Mater Sci Mater Med       Date:  2009-03-01       Impact factor: 3.896

10.  Live-cell, temporal gene expression analysis of osteogenic differentiation in adipose-derived stem cells.

Authors:  Hetal V Desai; Indu S Voruganti; Chathuraka Jayasuriya; Qian Chen; Eric M Darling
Journal:  Tissue Eng Part A       Date:  2012-09-05       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.